# A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus

> **NCT04177771** · — · TERMINATED · sponsor: **RxSight, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Aphakia
- Cataract
- Presbyopia

## Interventions

- **DEVICE:** Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population
- **DEVICE:** SofPort LI61AO IOL
- **DEVICE:** Tecnis ZCB00 or ZTC150 IOL

## Key facts

- **NCT ID:** NCT04177771
- **Lead sponsor:** RxSight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-15
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-20
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Technology changes.
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04177771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04177771, "A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04177771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*